Real-world outcomes of deucravacitinib in Chinese plaque psoriasis patients: a 24-week prospective study
<b>Conclusions:</b> These findings support the real-world effectiveness and safety of deucravacitinib in Chinese patients with plaque psoriasis; morphological observations are exploratory and hypothesis-generating.
Authors
- Zhouwei Wu
- Zhiwei Zhang (ORCID: https://orcid.org/0000-0001-8001-9606)
- Jin Zhou (ORCID: https://orcid.org/0000-0002-1534-2279)
- Xi Tan (ORCID: https://orcid.org/0000-0002-1177-6555)
Institutions
- Shanghai Jiao Tong University (CN)
- Tongren Hospital (CN)
Publication Details
- Journal
- Journal of Dermatological Treatment
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1080/09546634.2026.2635262
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.00